Viewing all links from the source for category: Pharma/Biotech

30/04/2025

Telix Provides Regulatory Update on TLX101-CDx

ImmVirX and Innovent Expand Collaboration to Investigate IVX037 with TYVYT® in Liver Cancer

Orthocell receives regulatory approval to commence sales of Remplir in US$84 million Thai market

Hansen Acquires Strategic Assets in Germany

Radiopharm Theranostics Doses First Patient with 18F-RAD101in U.S.Phase 2b Imaging Study of Brain Metastasis

Recce Pharmaceuticals Enters into DTRA-Backed Cooperative Research & Development Agreement with USAMRIID

28/04/2025

Lumos Diagnostics secures additional US Medicare reimbursement coverage for FebriDx with a further two MACs

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

24/04/2025

Orthocell appoints its first four US Remplir distributors with initial sales in the US expected near term

OneVentures preps new healthcare fund as government, LPs face losses

22/04/2025

Tilray Medical Introduces Cannabis Edibles in Australia

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

17/04/2025

Lumos secures further key US reimbursement milestones for FebriDX

Nyrada General Meeting Results

Clarity receives $11.1 million R&D Tax Incentive refund; Over $100 million in funding and refocus on high-priority programs

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

16/04/2025

Clarity: SECuRE trial update: First patient treated in the Phase II Cohort Expansion

Noxopharm: SOF-SKN™ successfully passes final pre-trial study

Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan

Nyrada Quarterly Activities Report & Appendix 4C

14/04/2025

AAMRI Submission – Strategic Examination of Research and Development Discussion Paper

ViiV Healthcare Australia announces recipients of 2024 Positive Action Community Grants – ViiV Healthcare Australia

Neuren confirms primary endpoints for Phase 3 trial of NNZ-2591 in PMS

Emyria Opens Second Empax Clinic to Meet Growing Demand and Payer Requirements

Mayne Pharma US legal proceedings

11/04/2025

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Orthocell submits regulatory application to start sales of Remplir in Hong Kong

Orthocell receives regulatory approval for Striate+ in Brazil: marks first market authorisation in Latin America

10/04/2025

Amplia Therapeutics: US Clinical Trial Activities for Narmafotinib Now Underway

Time to Prioritise Life Sciences: AusBiotech’s Federal Election Asks

Nyrada: Phase I Clinical Trial Dosing Update #1

09/04/2025

Cochlear statement on US tariff announcement

08/04/2025

Nyrada’s Neuroprotective Drug Advances With Key Partnerships

Cheaper weight loss drugs would boost economy: study

Nyrada: Significant Neuroprotection Achieved in Collaborative Traumatic Brain Injury Study

07/04/2025

Orthocell: landmark US FDA 510(k) clearance for flagship Remplir nerve repair product opens up US$1.6 billion US market

04/04/2025

TAI: Medicine price comparison between Australia and the United States

03/04/2025

Neuren Pharmaceuticals Limited – ANNUAL REPORT 2024

02/04/2025

Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

INOVIQ TO WORK WITH PETER MAC TO VALIDATE CAR-EXOSOME THERAPY

31/03/2025

Avecho receives US$3M upfront payment from Sandoz AG for license to commercialise CBD for insomnia in Australia

Novotech Report Reveals Growth in siRNA Research: Over 150 Industry-Sponsored Clinical Trials Conducted from 2020 to 2024

30/03/2025

Neuren Pharmaceuticals: Neuren initiates development of NNZ-2591 to treat HIE in newborns

28/03/2025

Amplia Therapeutics: ENCOURAGING UPDATED DATA FROM PANCREATIC CANCER TRIAL

American pharmaceutical boss does not support tariffs on Australian medicines

NNZ-2591, a Synthetic IGF-1 Metabolite Analog: Phase 2 Clinical Trial Resultsfor Children and Adolescents With Pitt Hopkins Syndrome

27/03/2025

Clinuvel: Positive preliminary results for PRÉNUMBRA® Instant in stroke patients

Xcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing

26/03/2025

Neurizon: NUZ-001 shows promising respiratory outcome

21/03/2025

These ASX companies are stepping up to tackle traumatic brain injury head-on